https://smallinsight.com/market-briefing/october-27th-a-bleak-day-as-antoic-bleeds-under-heavy-selling/ SmallInsight en 2026-10-27T15:15:24.000Z [Seoul Market Wrap] October 27th: A Bleak Day as Antoic Bleeds Under Heavy Selling https://smallinsight.com/corporate-analysis/aimed-bios-adc-leads-the-way-with-first-dosing-set-to-receive/ SmallInsight en 2026-10-27T14:34:59.000Z Aimed Bio's ADC Leads the Way with First Dosing, Set to Receive Subsequent Milestone Payments from Boehringer https://smallinsight.com/corporate-analysis/hd-modern-marine-solutions-suffers-relentless-selloff-analysts/ SmallInsight en 2026-10-27T14:23:04.000Z HD Modern Marine Solutions Suffers Relentless Selloff, Analysts Slash Price Targets https://smallinsight.com/stock-news/will-jeon-do-yeon-knock-on-the-oscar-door-americas-eyes-on/ SmallInsight en 2026-10-27T11:38:17.000Z Will Jeon Do-yeon Knock on the Oscar Door? America's Eyes on 'Possible Love' https://smallinsight.com/corporate-analysis/hlbs-rivoceranib-delivers-118-month-pfs-in-rare-cancer-prepares/ SmallInsight en 2026-10-27T10:38:00.000Z [ESMO 2026 Analysis] HLB's Rivoceranib Delivers 11.8-Month PFS in Rare Cancer; Prepares for U.S. Launch of Lifiting https://smallinsight.com/corporate-analysis/dae-woong-pharm-and-dnc-esthetics-unveiling-the-secrets-to/ SmallInsight en 2026-10-27T08:49:09.000Z Dae Woong Pharm and DNC Esthetics: Unveiling the Secrets to Comprehensive Treatment Strategies for Skin Rejuvenation and Facial Contouring https://smallinsight.com/editors-pick/antropics-historic-ipo-wall-street-joins-forces-shaking-up-the/ SmallInsight en 2026-10-27T08:30:28.000Z Antropic's Historic IPO: Wall Street Joins Forces, Shaking Up the AI Semiconductor Landscape https://smallinsight.com/corporate-analysis/hanall-biopharmas-vatocliumab-receives-chinese-approval-leading/ SmallInsight en 2026-10-27T08:06:59.000Z Hanall Biopharma's Vatocliumab Receives Chinese Approval, Leading to Global Phase III Trials for Next-Gen Antibodies https://smallinsight.com/corporate-analysis/abblifes-trio-of-pipeline-drugs-a-mixed-bag-of-approval-hurdles/ SmallInsight en 2026-10-26T15:50:07.000Z ABBLife's Trio of Pipeline Drugs: A Mixed Bag of Approval Hurdles and Phase 3 Preparations https://smallinsight.com/stock-news/ai-semiconductor-demand-remains-robust-but-growing-concerns-over/ SmallInsight en 2026-10-26T15:40:01.000Z AI Semiconductor Demand Remains Robust, but Growing Concerns Over Funding Pressures https://smallinsight.com/market-briefing/investor-confidence-plunges-ahead-of-super-week/ SmallInsight en 2026-10-26T15:15:49.000Z [Seoul Market Wrap] Investor Confidence Plunges Ahead of Super Week https://smallinsight.com/corporate-analysis/innometrys-small-insights-research-a-comprehensive-evolution-in/ SmallInsight en 2026-10-26T12:35:15.000Z Innometry's Small Insights Research: A Comprehensive Evolution in Testing, from Battery to Glass Substrates https://smallinsight.com/stock-news/nextraades-trading-volume-plunges-40-active-stocks-face/ SmallInsight en 2026-10-26T11:49:52.000Z Nextraade's Trading Volume Plunges 40%, Active Stocks Face Continuous Exclusion https://smallinsight.com/corporate-analysis/tovarsimig-unveils-clinical-results-for-bile-duct-cancer/ SmallInsight en 2026-10-26T10:17:52.000Z TovarsiMig Unveils Clinical Results for Bile Duct Cancer, Regulatory Talks Focus on Survival Metrics https://smallinsight.com/corporate-analysis/elon-musk-sells-hyundai-motors-buys-the-humanoid-robot-war/ SmallInsight en 2026-10-26T09:47:42.000Z Elon Musk Sells, Hyundai Motors Buys: The Humanoid Robot War Intensifies https://smallinsight.com/corporate-analysis/hlb-life-cares-tetraphos-expands-offline-reach-with-entry-into-e/ SmallInsight en 2026-10-26T08:20:09.000Z HLB Life Care's 'Tetraphos' Expands Offline Reach with Entry into E-Mart's Wow Shop https://smallinsight.com/corporate-analysis/altheogen-unveils-subcutaneous-adc-research-findings-at-esmo-2026/ SmallInsight en 2026-10-26T08:09:05.000Z Altheogen Unveils Subcutaneous ADC Research Findings at ESMO 2026 https://smallinsight.com/market-briefing/october-26th-a-crucial-week-for-south-koreas-markets/ SmallInsight en 2026-10-26T07:11:14.000Z [Seoul Pre-Market Brief] October 26th: A Crucial Week for South Korea's Markets https://smallinsight.com/stock-news/k-food-fever-from-noodles-to-snacks-and-fruits-a-sweet-success/ SmallInsight en 2026-10-25T16:48:49.000Z K-Food Fever: From Noodles to Snacks and Fruits, a Sweet Success Story https://smallinsight.com/editors-pick/k-beauty-revolution-indie-brands-drive-growth-shifting-focus-to/ SmallInsight en 2026-10-25T09:36:30.000Z K-Beauty Revolution: Indie Brands Drive Growth, Shifting Focus to Manufacturing and Distribution https://smallinsight.com/stock-news/foreign-electric-vehicles-overtake-domestic-china-dominates/ SmallInsight en 2026-10-24T17:44:20.000Z Foreign Electric Vehicles Overtake Domestic, China Dominates Supply Chain https://smallinsight.com/market-briefing/oil-surge-sends-markets-lower-semiconductor-rebound-offers-hope/ SmallInsight en 2026-10-24T07:16:56.000Z [Seoul Weekend Wrap] Oil Surge Sends Markets Lower, Semiconductor Rebound Offers Hope https://smallinsight.com/market-briefing/dow-plunges-123-as-oil-surge-drags-down-major-indices/ SmallInsight en 2026-10-24T06:28:45.000Z Dow Plunges 1.23% as Oil Surge Drags Down Major Indices https://smallinsight.com/market-briefing/kospi-recovers-to-5550-mark-kosdaq-bleeds-under-heavy-selling/ SmallInsight en 2026-10-23T17:29:16.000Z [Seoul Market Wrap] KOSPI Recovers to 5550-Mark, KOSDAQ Bleeds Under Heavy Selling for Second Straight Day https://smallinsight.com/stock-news/eus-carbon-barrier-threatens-auto-parts-electronics-south-koreas/ SmallInsight en 2026-10-23T16:31:30.000Z EU's Carbon Barrier Threatens Auto Parts, Electronics; South Korea's Exporters on Edge